ATE142699T1 - Zellulosebindende fusionsproteine - Google Patents

Zellulosebindende fusionsproteine

Info

Publication number
ATE142699T1
ATE142699T1 AT89907798T AT89907798T ATE142699T1 AT E142699 T1 ATE142699 T1 AT E142699T1 AT 89907798 T AT89907798 T AT 89907798T AT 89907798 T AT89907798 T AT 89907798T AT E142699 T1 ATE142699 T1 AT E142699T1
Authority
AT
Austria
Prior art keywords
polypeptide
cellulose
binding region
fusion protein
affinity matrix
Prior art date
Application number
AT89907798T
Other languages
English (en)
Inventor
Douglas G Kilburn
Robert C Miller
Richard A J Warren
Neil R Gilkes
Original Assignee
Univ British Columbia
Douglas G Kilburn
Robert C Miller
Richard A J Warren
Neil R Gilkes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia, Douglas G Kilburn, Robert C Miller, Richard A J Warren, Neil R Gilkes filed Critical Univ British Columbia
Application granted granted Critical
Publication of ATE142699T1 publication Critical patent/ATE142699T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08HDERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H8/00Macromolecular compounds derived from lignocellulosic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/55IL-2
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • C12N11/12Cellulose or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2434Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2437Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2434Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2445Beta-glucosidase (3.2.1.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01004Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01021Beta-glucosidase (3.2.1.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01091Cellulose 1,4-beta-cellobiosidase (3.2.1.91)
    • DTEXTILES; PAPER
    • D21PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21HPULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H17/00Non-fibrous material added to the pulp, characterised by its constitution; Paper-impregnating material characterised by its constitution
    • D21H17/005Microorganisms or enzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/33Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/50Fusion polypeptide containing protease site
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/61Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/803Physical recovery methods, e.g. chromatography, grinding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813Carrier is a saccharide
    • Y10S530/814Cellulose or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
AT89907798T 1988-07-08 1989-06-28 Zellulosebindende fusionsproteine ATE142699T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/216,794 US5137819A (en) 1988-07-08 1988-07-08 Cellulose binding fusion proteins for immobilization and purification of polypeptides

Publications (1)

Publication Number Publication Date
ATE142699T1 true ATE142699T1 (de) 1996-09-15

Family

ID=22808538

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89907798T ATE142699T1 (de) 1988-07-08 1989-06-28 Zellulosebindende fusionsproteine

Country Status (7)

Country Link
US (2) US5137819A (de)
EP (1) EP0381719B1 (de)
JP (1) JP2528721B2 (de)
AT (1) ATE142699T1 (de)
CA (1) CA1335182C (de)
DE (1) DE68927161T2 (de)
WO (1) WO1990000609A1 (de)

Families Citing this family (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048715A (en) * 1988-07-08 2000-04-11 Univ. Of British Columbia Two-phase partition affinity separation system and affinity separated cell-containing composition
US5340731A (en) * 1988-07-08 1994-08-23 University Of British Columbia Method of preparing a B-1,4 glycan matrix containing a bound fusion protein
US6174700B1 (en) * 1988-07-08 2001-01-16 University Of British Columbia Purification of a polypeptide compound having a polysaccharide binding domain by affinity phase separation
US5595887A (en) * 1990-07-16 1997-01-21 Bionebraska, Inc. Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment
EP0496861A1 (de) * 1990-08-17 1992-08-05 Her Majesty In Right Of Canada As Represented By The National Research Council Of Canada Herstellung rekombinanter dna von beta-1,3-glucanase
US6512166B1 (en) 1991-06-17 2003-01-28 Cornell Research Foundation, Inc. Combinations of fungal cell wall degrading enzyme and fungal cell membrane affecting compound
US6020540A (en) * 1993-04-14 2000-02-01 Cornell Research Foundation, Inc. Gene encoding endochitinase
EP0611306B1 (de) * 1991-11-08 1998-07-08 Somatogen, Inc. Hämoglobine als arzneimittelabgabesystem
US5872094A (en) * 1993-01-06 1999-02-16 The General Hospital Corporation Method for attaching cartilaginous tissue, cartilage matrix protein or link protein to a surface
US5496934A (en) * 1993-04-14 1996-03-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Nucleic acids encoding a cellulose binding domain
US7005128B1 (en) 1993-12-17 2006-02-28 Genencor International, Inc. Enzyme feed additive and animal feed including it
US6268196B1 (en) 1993-12-17 2001-07-31 Genencor International, Inc. Method and compositions for treating cellulose containing fabrics using truncated cellulase enzyme compositions
US5861271A (en) * 1993-12-17 1999-01-19 Fowler; Timothy Cellulase enzymes and systems for their expressions
GB9400623D0 (en) * 1994-01-14 1994-03-09 Univ Leeds Exploitation of the cellulase enzyme complex of neurospora
IL111415A0 (en) * 1994-10-27 1994-12-29 Yeda Res & Dev Modified cellulose-binding domain (cbd) proteins and use thereof
US5536501A (en) * 1994-12-30 1996-07-16 Proguard, Inc. Use of flavenoid aldehydes as insecticides and for killing arachnids
US6750256B1 (en) * 1994-12-30 2004-06-15 Proguard, Inc. Use of aromatic aldehydes as insecticides
US6251951B1 (en) 1994-12-30 2001-06-26 Proguard, Inc Use of flavonoid and aromatic aldehydes as pesticides
CN102080070B (zh) 1995-03-17 2016-01-20 诺沃奇梅兹有限公司 新的内切葡聚糖酶
US5639794A (en) * 1995-06-07 1997-06-17 Proguard, Inc. Use of saponin in methods and compositions for pathogen control
US5843375A (en) * 1995-06-07 1998-12-01 Proguard, Inc. Method for decontamination of a liquid of gaseous environment
US5792467A (en) * 1995-06-07 1998-08-11 Proguard, Inc. Repellent compositions containing aromatic aldehydes
US5874308A (en) * 1996-01-16 1999-02-23 University Of British Columbia Compositions and methods for modulating cell proliferation using growth factor-polysaccharide binding fusion proteins
AR005601A1 (es) * 1996-01-29 1999-06-23 Novozymes As Proceso para la remocion o blanqueo de suciedad o manchas presentes en telas celulosicas y proceso para el lavado de telas celulosicas manchadas o sucias y composicion detergente
WO1997028256A1 (en) * 1996-01-29 1997-08-07 Novo Nordisk A/S Process for desizing cellulosic fabric
WO1997040229A1 (en) * 1996-04-19 1997-10-30 Novo Nordisk A/S Fabric treated with a cellulase and a hybrid enzyme comprising a phenol oxidizing enzyme
WO1997040127A1 (en) * 1996-04-19 1997-10-30 Novo Nordisk A/S Bleaching of fabric with a hybrid enzyme containing a phenol oxidizing enzyme fused to a cellulose binding domain
GB9613758D0 (en) 1996-07-01 1996-09-04 Unilever Plc Detergent composition
EP0935665B1 (de) * 1996-09-30 2008-03-19 BASF Plant Science GmbH Einkapselung von polypeptiden in die stärkematrix
ATE386799T1 (de) * 1996-10-28 2008-03-15 Novozymes As Extrazelluläre expression von zellulose bindenden domänen (cbd) unter verwendung von bacillus
US20020168718A1 (en) * 1997-04-03 2002-11-14 California Institute Of Technology Enzyme-mediated modification of fibrin for tissue engineering
IL121404A0 (en) 1997-07-27 1998-01-04 Yissum Res Dev Co Transgenic higher plants of altered structural morphology
GB9718415D0 (en) * 1997-08-29 1997-11-05 Smithkline Beecham Plc Formulation
TW552268B (en) 1997-10-08 2003-09-11 Yun-Ru Chen Chimeric proteins with a cellulose binding domain (CBD)
US6323023B1 (en) 1998-01-13 2001-11-27 Yissum Research Development Co., Ltd. Vectors containing nucleic acids coding for Arabidopsis thaliana endo-1,4-β-glucanase secretion signal peptide
WO1999042121A1 (en) 1998-02-20 1999-08-26 University Of Miami Modified heat shock protein-antigenic peptide complex
US6315900B1 (en) * 1998-06-03 2001-11-13 Accurate Polymers Static separation method using non-porous cellulose beads
BRPI9911086B1 (pt) 1998-06-10 2016-08-02 Novozymes As composição de limpeza, processo para tratar tecidos a máquina, e uso de uma mananase
US6894022B1 (en) 1998-08-27 2005-05-17 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
US7241730B2 (en) 1998-08-27 2007-07-10 Universitat Zurich Enzyme-mediated modification of fibrin for tissue engineering: fibrin formulations with peptides
US7601685B2 (en) * 1998-08-27 2009-10-13 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
WO2001034902A2 (en) * 1999-11-08 2001-05-17 Cbd Technologies Ltd. Process and composition for preparing a lignocellulose-based product, and the product obtained by the process
IL133134A0 (en) * 1999-11-25 2001-03-19 American Israeli Paper Mills Improved paper products
KR20040002853A (ko) 2001-01-19 2004-01-07 비로노바티브 비.브이. 감응성 포유류에서 호흡계 질환을 유발하는 바이러스
US7067148B2 (en) 2001-02-15 2006-06-27 King Pharmaceutical Research & Development, Inc. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
ES2521615T3 (es) 2001-06-06 2014-11-13 Novozymes A/S Endo-beta-1,4-glucanasa
GR20010100295A (el) 2001-06-18 2003-02-27 Εμμανουηλ Παττακος Μεταβλητο συστημα βαλβιδων
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
DE60231417D1 (de) * 2001-10-03 2009-04-16 Unilever Nv Kohlenhydratbindungsdomäne enthaltende fusionsproteine zur verabreichung von therapeutischen und anderen stoffen und zusammensetzungen in denen die fusionsproteine enthalten sind
US7247609B2 (en) * 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
EP1485468A4 (de) 2002-02-21 2007-01-03 Medimmune Vaccines Inc Rekombinante parainfluenzavirus-expressionssysteme und impfstoffe mit aus metapneumovirus stammenden heterologen antigenen
IL163880A0 (en) * 2002-03-07 2005-12-18 Zephyr Proteomix Ltd Microarrays of cellulose binding chimeric proteinsand methods of use thereof
US20060035342A1 (en) * 2002-09-12 2006-02-16 Withers Stephen G Engineered enzymes and their use for synthesis of thioglycosides
WO2004031379A1 (en) * 2002-10-01 2004-04-15 Unilever N.V. Proteins having polysaccharidase activity
EP2319318A3 (de) 2003-03-27 2011-08-17 PTC Therapeutics, Inc. Verfahren zur Identifizierung von Verbindungen mit tRNA-Splicing Endonuklease als Aufhänger, und Verwendungen für diese Verbindungen als anti-Proliferationsmittel
EP1613160A4 (de) 2003-03-27 2008-01-02 Ptc Therapeutics Inc Betrachtung von enzymen des trna-splice-wegs zur identifikation von antifungalen und/oder proliferationshemmenden molekülen
CN101410519B (zh) 2003-04-25 2013-04-24 免疫医疗有限责任公司 间质肺病毒株及其在疫苗制剂中以及用作抗原性序列表达载体的用途和繁殖病毒的方法
WO2005003311A2 (en) 2003-06-25 2005-01-13 Novozymes A/S Enzymes for starch processing
ES2383366T3 (es) 2003-06-25 2012-06-20 Novozymes A/S Enzimas para el tratamiento de almidón
US20050054752A1 (en) * 2003-09-08 2005-03-10 O'brien John P. Peptide-based diblock and triblock dispersants and diblock polymers
WO2005023981A2 (en) * 2003-09-09 2005-03-17 Zephyr Proteomix Ltd. Libraries of chimeric cellulose binding proteins and methods of use thereof
CA2538794C (en) 2003-09-12 2016-04-19 Antigenics, Inc. Vaccine for treatment and prevention of herpes simplex virus infection
EP1687419B1 (de) 2003-10-28 2010-02-03 Novozymes North America, Inc. Hybridenzyme
DE602004022967D1 (de) 2003-10-30 2009-10-15 Novozymes As Kohlenhydratbindende module
US8097445B2 (en) * 2004-03-25 2012-01-17 Danisco Us Inc. Exo-endo cellulase fusion protein
RU2278160C2 (ru) * 2004-04-13 2006-06-20 Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) РЕКОМБИНАНТНЫЙ БЕЛОК LACspCBD, ОБЛАДАЮЩИЙ БЕТА-ГАЛАКТОЗИДАЗНОЙ АКТИВНОСТЬЮ И СПОСОБНОСТЬЮ САМОПРОИЗВОЛЬНО СВЯЗЫВАТЬСЯ С ЦЕЛЛЮЛОЗОСОДЕРЖАЩИМИ СОРБЕНТАМИ, РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК, КОДИРУЮЩАЯ СИНТЕЗ РЕКОМБИНАНТНОГО БЕЛКА LACspCBD, ШТАММ Escherichia coli M15 [pREP4, pLACspCBD] - ПРОДУЦЕНТ РЕКОМБИНАНТНОГО БЕЛКА LACspCBD, СПОСОБ ПОЛУЧЕНИЯ ИММОБИЛИЗОВАННОГО РЕКОМБИНАНТНОГО БЕЛКА LACspCBD НА ЦЕЛЛЮЛОЗЕ И СПОСОБ ФЕРМЕНТАТИВНОГО РАСЩЕПЛЕНИЯ ЛАКТОЗЫ
EP1831384B1 (de) 2004-12-22 2015-08-12 Novozymes A/S Polypeptide mit glucoamylase-aktivität und diese codierende polynukleotide
CA2592083C (en) 2004-12-22 2017-02-21 Novozymes A/S Hybrid enzymes consisting of an endo-amylase first amino acid sequence and a carbohydrate-binding module as second amino acid sequence
US20060147443A1 (en) * 2004-12-22 2006-07-06 Kuros Biosurgery Ag Synthetic biomaterials having incorporated therein bioactive factors through enzymatically degradable linkages
US8575101B2 (en) 2005-01-06 2013-11-05 Kuros Biosurgery Ag Supplemented matrices for the repair of bone fractures
WO2006073711A2 (en) * 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
MX2007008319A (es) * 2005-01-06 2007-10-04 Kuros Biosurgery Ag Matrices suplementadas para la reparacion de fracturas oseas.
US7662918B2 (en) * 2005-03-03 2010-02-16 Simpson Biotech Co., Ltd. Recombinant protein comprising starch binding domain and use thereof
WO2007076128A2 (en) 2005-12-23 2007-07-05 Nanostring Technologies, Inc. Nanoreporters and methods of manufacturing and use thereof
PT103410B (pt) * 2005-12-23 2009-04-21 Univ Do Minho Proteínas modificadas compreendendo um péptido/proteína bioactivo(a) ligado(a) a uma sequência de aminoácidos que contém um módulo humano de ligação a carbohidratos (cbm), e desenvolvimento de um sistema de administração de proteínas terapeuticamente
CA2653095C (en) * 2006-05-22 2013-07-16 Nanostring Technologies, Inc. Systems and methods for analyzing nanoreporters
CN101473032B (zh) 2006-06-21 2013-08-21 诺维信北美公司 脱浆和煮炼方法
DE102007002580A1 (de) * 2007-01-11 2008-07-17 C-Lecta Gmbh Proteolytische Abspaltung von Protein-Tags in der rekombinanten Protein-Herstellung
CA2687292C (en) * 2007-04-10 2017-07-04 Nanostring Technologies, Inc. Methods and computer systems for identifying target-specific sequences for use in nanoreporters
DK2136850T3 (da) * 2007-04-13 2012-04-10 Kuros Biosurgery Ag Polymervævforsegling
JP2011504374A (ja) * 2007-11-26 2011-02-10 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド 繊維状ポリペプチドおよび多糖を含む組成物
WO2009083544A2 (en) * 2007-12-28 2009-07-09 Kuros Biosurgery Ag Pdgf fusion proteins incorporated into fibrin foams
DK2257301T3 (da) 2008-03-03 2014-04-28 Univ Miami Immunterapi baseret på allogene cancerceller.
JP2011515399A (ja) 2008-03-20 2011-05-19 ユニバーシティー オブ マイアミ 熱ショックタンパクgp96ワクチン接種及びそれを用いた方法
CN102088991A (zh) 2008-05-13 2011-06-08 堪萨斯大学 金属提取肽标签和相关方法
US8519115B2 (en) 2008-08-14 2013-08-27 Nanostring Technologies, Inc. Stable nanoreporters
RU2011144575A (ru) 2009-04-03 2013-05-10 Эйдженус Инк. Способы получения и применения мультишаперон-антигенных комплексов
US20100291656A1 (en) 2009-05-15 2010-11-18 Simpson Biotech Co., Ltd. Method and system for protein purification
RU2428477C2 (ru) * 2009-05-15 2011-09-10 Дмитрий Викторович Гришин РЕКОМБИНАНТНАЯ БЕЛКОВАЯ КОНСТРУКЦИЯ ДСД-сп-β-ГАЛ, ОБЛАДАЮЩАЯ АКТИВНОСТЬЮ ФЕРМЕНТА ТЕРМОСТАБИЛЬНОЙ β-ГАЛАКТОЗИДАЗЫ (ЛАКТАЗЫ) И СПОСОБНОСТЬЮ АФФИННО СВЯЗЫВАТЬСЯ С ДЕКСТРАНОМ, ПЛАЗМИДНАЯ ДНК pGD-10, ОПРЕДЕЛЯЮЩАЯ БИОСИНТЕЗ ДСД-сп-β-ГАЛ, И ШТАММ-ПРОДУЦЕНТ Escherichia coli DH5α/PGD-10
US8785159B2 (en) * 2009-11-25 2014-07-22 Alliance For Sustainable Energy, Llc Extracellular secretion of recombinant proteins
ES2377617B1 (es) 2010-08-31 2012-11-23 Iden Biotechnology, S.L. Procedimiento para la producción y purificación de proteínas recombinantes en plantas.
EP2686027B1 (de) 2011-03-16 2021-05-05 Kuros Biosurgery AG Pharmazeutische formulierung zur verwendung für die wirbelsäulenfusion
WO2012149333A1 (en) 2011-04-29 2012-11-01 Danisco Us Inc. Detergent compositions containing bacillus sp. mannanase and methods of use thereof
EP2712363A1 (de) 2011-04-29 2014-04-02 Danisco US Inc. Waschmittelzusammensetzungen mit geobacillus tepidamans mannanase und verfahren zu ihrer verwendung
AR086214A1 (es) 2011-04-29 2013-11-27 Danisco Us Inc Composiciones detergentes que contienen mananasa de bacillus agaradhaerens y sus metodos de uso
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
EP2904099B1 (de) 2012-10-05 2018-12-19 Novozymes A/S Verhindern von bakterienadhäsion
WO2014100018A1 (en) 2012-12-19 2014-06-26 Danisco Us Inc. Novel mannanase, compositions and methods of use thereof
AU2014278152A1 (en) 2013-06-14 2015-12-24 Nanostring Technologies, Inc. Multiplexable tag-based reporter system
WO2015049370A1 (en) 2013-10-03 2015-04-09 Novozymes A/S Detergent composition and use of detergent composition
EA201792501A1 (ru) 2015-05-13 2018-10-31 Эйдженус Инк. Вакцины для лечения и профилактики рака
JP7364330B2 (ja) 2015-11-05 2023-10-18 ダニスコ・ユーエス・インク パエニバチルス(Paenibacillus)属種及びバチルス(Bacillus)属種のマンナナーゼ
EP4141113A1 (de) 2015-11-05 2023-03-01 Danisco US Inc Paenibacillus sp. mannanasen
EP3181153A1 (de) 2015-12-18 2017-06-21 BSN medical GmbH Wundpflegeprodukt mit ecm-funktionalisierter nanocellulose
IL247569A0 (en) 2016-08-30 2016-11-30 Yeda Res & Dev An enzymatic complex for the breakdown of lignocellulosic material
EP3315145B2 (de) 2016-10-28 2025-07-16 BSN medical GmbH Mehrschichtiges wundpflegeprodukt mit perforierter kollagenschicht
WO2019197318A1 (en) 2018-04-09 2019-10-17 Novozymes A/S Polypeptides having alpha-amylase activity and polynucleotides encoding same
MA52363A (fr) 2018-04-26 2021-03-03 Agenus Inc Compositions peptidiques de liaison à une protéine de choc thermique (hsp) et leurs méthodes d'utilisation
US11920290B2 (en) 2020-01-14 2024-03-05 Sanko Tekstil Isletmeleri San. Ve Tic A.S. Process for dyeing textiles and enzymes used therein
WO2024050339A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Mannanase variants and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3410437A1 (de) * 1984-03-22 1985-09-26 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von proteinen
EP0195680A3 (de) * 1985-03-21 1987-06-10 Immunex Corporation Proteinsynthese mit einem Identifizierungspeptid
US4745055A (en) * 1985-05-07 1988-05-17 California Biotechnology Inc. Fused protein for enzyme immunoassay system
EP0244147A3 (de) * 1986-04-28 1989-04-05 Merck & Co. Inc. Verfahren zur Reinigung hybrider Proteine
DE286239T1 (de) * 1987-03-10 1994-02-24 New England Biolabs Inc Herstellung und Reinigung eines Proteins, das mit einem Bindungsprotein fusioniert ist.

Also Published As

Publication number Publication date
DE68927161T2 (de) 1997-01-30
EP0381719B1 (de) 1996-09-11
US5137819A (en) 1992-08-11
CA1335182C (en) 1995-04-11
JP2528721B2 (ja) 1996-08-28
US5202247A (en) 1993-04-13
WO1990000609A1 (en) 1990-01-25
JPH03501261A (ja) 1991-03-22
DE68927161D1 (de) 1996-10-17
EP0381719A1 (de) 1990-08-16

Similar Documents

Publication Publication Date Title
DE68927161D1 (de) Zellulosebindende fusionsproteine
Brown et al. Location of disulphide bridges by diagonal paper electrophoresis: the disulphide bridges of bovine chymotrypsinogen A
Van Tilbeurgh et al. Limited proteolysis of the cellobiohydrolase I from Trichoderma reesei: Separation of functional domains
US5270176A (en) Method for the selective cleavage of fusion proteins with lysostaphin
ES2114539T3 (es) Expresion de polipeptidos recombinados con purificacion mejorada.
DE69227041D1 (de) Expression und reinigung von rekombinantem, löslichem gewebefaktor
Dando et al. Human thimet oligopeptidase
IL130403A (en) Oil bodies and associated proteins as affinity matrices
BR9507618A (pt) Frações polipeptidicas solúveis da proteína lag-3 processo de produção composição terapêutica anticorpos anti-idiotipo
ATE212059T1 (de) Methoden zur identifizierung heterofunktionaler fusionsproteine
Breithaupt et al. Isolation and characterization of three phospholipases A from the crotoxin complex
WO1994003611A3 (en) Ptp-d subfamily of protein tyrosine phosphatases
Senior et al. Mitochondrial" Structural Protein": A REASSESSMENT
Viljoen et al. Isolation and amino acid sequence of caudoxin, a presynaptic acting toxic phospholipase A2 from the venom of the horned puff adder (Bitis caudalis)
EK et al. Specific cleavage of the fibroblast receptor for platelet‐derived growth factor by an endogenous Ca2+‐dependent thiol protease
Soffer Enzymatic Modification of Proteins: IV. ARGINYLATION OF BOVINE THYROGLOBULIN
ITRM920658A1 (it) Procedimento per la purificazione della proteina big endotelina
Romero et al. Purification and amino acid sequence of aminopeptidase P from pig kidney
Himeno et al. The Synthesis of Rat Liver Lysosomes: III. Chemical Composition of Microsomal and Lysosomal β-Glucuronidases Purified from Rat Liver
JPS6467197A (en) Enzymatically inactive and immunologically active b-galatosidase-mutagenic protein, its preparation, immulogical assay of serum protein, and enzyme-immunoassay reagent
Gong et al. Affinity chromatography of endoglucanase of Trichoderma viride by concanavalin A–agarose
Tanenbaum et al. Some molecular properties of pneumoccal neuraminidase isoenzymes
Toffoletto et al. Enkephalin is liberated from metorphamide and dynorphin A1-8 by endo-oligopeptidase A, but not by metalloendopeptidase EC 3.4. 24.15
Carden et al. Chemical cross-linking analyses of ox neurofilaments
Marks et al. Observations on Nα‐deacetylation of model amino acids and peptides: distribution and purification of a specific N‐acyl amino acid releasing enzyme in rat brain

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee